The Fasting Mimicking Diet:
Learn how to incorporate fasting into your practice.

Tuesday, April 29th, 2022, 7pm


The Fasting Mimicking Diet (FMD) has been shown in a clinical trial to reduce risk factors for metabolic syndrome and other age-related diseases. There are over 20 trials on FMD underway or completed for diabetes, metabolic syndrome, PCOS, infertility, depression, ulcerative colitis, obesity, cancer support, poor immunity, and for reduction of biomarkers of chronic disease.

Intermittent fasting diets are the most popular diets searched for online. Healthcare practitioners need to know the mechanism of action and medical benefits of fasting and intermittent fasting diets to provide patients with informed guidance. Strategic use of intermittent fasting has significant benefits, and it is simple to administer and incorporate into clinical practice.

This webinar presents a unique opportunity to stay ahead of scientific breakthroughs in the fasting field, followed by a Q&A session.

If you are interested in receiving further information about ProLon FMD or would like us to call you, please don’t hesitate to contact L-Nutra Customer Service. You can also register on the ProLon website for educational material and to purchase ProLon at the wholesale price.

Michael Thomsen completed studies in Naturopathy and Herbal Medicine in Sydney, graduating in 1986. He has a Master of Science, Graduate School of Integrative Medicine, from Swinburne University. Michael is the General Manager of L-Nutra Australia. He has undertaken fasting many times and has assisted hundreds of people undertaking the fasting mimicking diet.